Acquired hemophilia a hemostatic treatment with recombinant porcine factor VIII

被引：0
|
作者：
Sobolewska, A. [2 ]
Urbanska, A. [2 ]
Bednarska, M. [2 ]
Zawadzka, I. [2 ]
Witkowski, M. [1 ]
机构：
[1] Copernicus Mem Hosp, Dept Gen Haematol, Lodz, Poland
[2] Med Lab Synevo Copernicus, Lodz, Poland
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118418
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1400
引用
收藏
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Curry, N.
    Knoebl, P.
    Percy, C.
    Santoro, R.
    Schmaier, A. H.
    Trautmann-Grill, K.
    Badejo, K.
    Chen, J.
    Nouri, M.
    Oberai, P.
    Klamroth, R.
    HAEMOPHILIA, 2023, 29 : 101 - 102
  • [42] REAL-WORLD SAFETY AND EFFECTIVENESS OF RECOMBINANT B-DOMAIN-DELETED PORCINE-SEQUENCE FACTOR VIII FOR ACQUIRED HEMOPHILIA A
    Miesbach, W.
    Knoebl, P.
    Santoro, R.
    Chen, J.
    Tripkovic, N.
    Percy, C. L.
    Schmaier, A. H.
    Klamroth, R.
    HAEMOPHILIA, 2021, 27 : 119 - 119
  • [43] Structure Determination of a Bioengineered Human/Porcine Factor VIII for Hemophilia a Treatment, and Improvements to the Human Factor VIII Model
    Smith, Ian
    Spiegel, Clint
    PROTEIN SCIENCE, 2018, 27 : 201 - 202
  • [44] An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy
    Sternberg, Anna R.
    Davidson, Robert J.
    Wilhelm, Amelia R.
    George, Lindsey A.
    MOLECULAR THERAPY, 2022, 30 (04) : 328 - 329
  • [45] THE TREATMENT OF ACQUIRED FACTOR-VIII INHIBITORS - WORLDWIDE EXPERIENCE WITH PORCINE FACTOR-VIII CONCENTRATE
    KESSLER, CM
    LUDLAM, CA
    SEMINARS IN HEMATOLOGY, 1993, 30 (02) : 22 - 27
  • [46] Treatment of an acquired factor VIII inhibitor with sequential recombinant factor VIIa and FEIBA
    Miranda, G. G.
    Rodgers, G. M.
    HAEMOPHILIA, 2009, 15 (01) : 383 - 385
  • [47] Recombinant porcine factor VIII: Lessons from the past and place in the management of hemophilia A with inhibitors in 2021
    Dargaud, Yesim
    Escuriola-Ettingshausen, Carmen
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (08)
  • [48] Acquired haemophilia A treated with recombinant porcine factor VIII: a single centre UK experience
    Khan, Dalia
    Raza-Burton, Sayma
    Baker, Peter
    Harper, Sarah
    Beavis, James
    Desborough, Michael
    Shapiro, Susan
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : E128 - E131
  • [49] TREATMENT OF SERIOUS BLEEDS IN A PROSPECTIVE CLINICAL TRIAL WITH A B-DOMAIN DELETED RECOMBINANT PORCINE SEQUENCE FACTOR VIII (OBI-1) IN PATIENTS WITH ACQUIRED HEMOPHILIA A
    Kruse-Jarres, Rebecca
    St-Louis, Jean
    Greist, Anne
    Shapiro, Amy
    Smith, Hedy
    Chowdary, Pratima
    Drebes, Anja
    Gomperts, Edward
    Chapman, Miranda
    Mo, Min
    Novack, Aaron
    Farin, Heinrich
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E41 - E42
  • [50] Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice
    Ovlisen, K.
    Kristensen, A. T.
    Valentino, L. A.
    Hakobyan, N.
    Ingerslev, J.
    Tranholm, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (06) : 969 - 975
12345